首页 正文

[Recent research on tofacitinib in the treatment of pediatric rheumatic diseases]

{{output}}
Tofacitinib is a Janus kinase inhibitor and can block the Janus kinase-signal transducer and activator of transcription signal transduction pathway and reduce the production and release of a variety of cytokines. It has great potential in the treatment of vari... ...